Skip to main content

Waters Plans New MS Headquarters in UK

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today announced a land-purchase agreement with the Royal Bank of Scotland where it will build a new mass spectrometry headquarter in Wilmslow, Cheshire in the UK.

The new facility, to be situated on the 37-acre Stamford Lodge site, will bring together Waters' mass spec operations located on four separate sites in South Manchester and Altrincham. The facility will include state-of-the-art customer demonstration laboratories, R&D capabilities, and expanded manufacturing capacity.

The new headquarters "will be designed to accelerate the fate of innovation with increased access for the world's scientific thought leaders," said Brian Smith, Waters' vice president of MS business operations, said in a statement.

Final sale of the land is subject to planning and building permission from the Cheshire East Council. It is expected to open in 2013.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.